HEXIM1 Activators
HEXIM1, or Hexamethylene bisacetamide-inducible protein 1, is a critical regulator of transcriptional elongation and RNA processing in eukaryotic cells. Functionally, HEXIM1 exerts its effects by interacting with the positive transcription elongation factor b (P-TEFb) complex, which comprises cyclin-dependent kinase 9 (CDK9) and cyclin T1 or T2 subunits. Through its association with the P-TEFb complex, HEXIM1 serves as a negative regulator of transcription by sequestering CDK9 in an inactive complex, thereby blocking RNA polymerase II phosphorylation and transcriptional elongation. Additionally, HEXIM1 functions as a scaffold protein, orchestrating the assembly of multiprotein complexes involved in various cellular processes, including RNA splicing, mRNA export, and microRNA biogenesis. Its role in coordinating transcriptional and post-transcriptional events underscores the significance of HEXIM1 in fine-tuning gene expression programs essential for cellular homeostasis and development.
Activation of HEXIM1 is governed by a multitude of regulatory mechanisms operating at both the transcriptional and post-translational levels. Transcriptional activation of HEXIM1 gene expression is mediated by diverse signaling pathways and transcription factors responsive to cellular stress, growth factors, and differentiation cues. Notably, environmental cues such as DNA damage, oxidative stress, and hypoxia trigger the induction of HEXIM1 expression, highlighting its role as a stress-responsive gene involved in cellular adaptation and survival. Furthermore, post-translational modifications, including phosphorylation, acetylation, and ubiquitination, modulate HEXIM1 activity and stability, thereby influencing its interaction with P-TEFb and other binding partners. Elucidating the intricate mechanisms underlying HEXIM1 activation provides valuable insights into the regulation of transcriptional elongation and RNA processing, shedding light on its pivotal role in controlling gene expression dynamics in health and disease.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
db-cAMP, a cell-permeable cAMP analog, activates protein kinase A (PKA). PKA activation leads to phosphorylation of the C-terminal domain (CTD) of RNA polymerase II, which can promote transcriptional elongation. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing intracellular levels of cAMP and subsequently activating PKA. Activation of PKA can initiate a cascade resulting in the phosphorylation of transcription factors and RNA polymerase II, altering their activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which in turn can phosphorylate targets that promote transcription. PKC-mediated phosphorylation can lead to the activation of signal transduction pathways that result in the release of P-TEFb from HEXIM1, allowing HEXIM1 to activate. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. Elevated calcium can activate calmodulin-dependent kinase, which can phosphorylate substrates involved in the transcriptional regulation. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that increases cAMP levels, activating PKA. PKA then phosphorylates various proteins involved in transcriptional regulation, which can cause the redistribution of P-TEFb, allowing HEXIM1 to disengage and become active. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4 (PDE4), leading to an increase in cAMP levels. Elevated cAMP activates PKA, which then phosphorylates proteins that govern the dynamics between P-TEFb and HEXIM1, causing HEXIM1 to release its inhibition and become active. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
(+/-)-JQ1 binds to bromodomains of BET proteins, dislocating them from chromatin. This displacement can enhance the recruitment of positive transcription elongation factors, including P-TEFb, to transcriptional start sites. | ||||||
Prostratin | 60857-08-1 | sc-203422 sc-203422A | 1 mg 5 mg | $141.00 $541.00 | 24 | |
Prostratin is a PKC activator, which can phosphorylate proteins within the transcription machinery and signaling pathways related to transcriptional activation. This can lead to the rearrangement of P-TEFb-containing complexes and result in the activation of HEXIM1. | ||||||
Bryostatin 1 | 83314-01-6 | sc-201407 | 10 µg | $245.00 | 9 | |
Bryostatin 1 is a PKC activator and can modulate transcription by influencing the phosphorylation status of transcription-related proteins. The alteration in phosphorylation can disrupt the interaction between HEXIM1 and P-TEFb, promoting the activation of HEXIM1. | ||||||